We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current SEMHF market cap is 56.64B. The company's latest EPS is EUR 1.7349 and P/E is 27.24.
| Year End 30 September 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 14.46B | 18B | 21.71B | 21.68B | 22.36B |
| Operating Income | 1.98B | 2.57B | 2.93B | 2.14B | 2.81B |
| Net Income | 1.41B | 1.73B | 2.04B | 1.51B | 1.94B |
| Year End 30 September 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 25.09B | 42.16B | 49.06B | 46.68B | 46.06B |
| Total Liabilities | 12.58B | 25.82B | 29.2B | 28.55B | 27.81B |
| Total Equity | 12.51B | 16.34B | 19.85B | 18.13B | 18.25B |
| Year End 30 September 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | 1.93B | 2.93B | 2.5B | 2.12B | 2.83B |
| Investing | -1.91B | -14.14B | -868M | -1.07B | -666M |
| Financing | -249M | 11.84B | -1.64B | -690M | -1.66B |
| Market Cap | 56.64B |
| Price to Earnings Ratio | 27.24 |
| Price to Sales Ratio | 2.37 |
| Price to Cash Ratio | 19.72 |
| Price to Book Ratio | 2.9 |
| Dividend Yield | 4.93% |
| Shares Outstanding | 1.12B |
| Average Volume (1 week) | 246 |
| Average Volume (1 Month) | 1.32k |
| 52 Week Change | -5.17% |
| 52 Week High | 60.00 |
| 52 Week Low | 46.83 |
| Spread (Intraday) | 3.33 (6.02%) |
| Company Name | Siemens Healthineers AG NA O N (PK) |
| Address |
henkestrasse 127 erlangen 91052 |
| Website | https://www.siemens-healthineers.com |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
